Amy Feldman, Forbes Staff

Author's posts

Forbes 2022 Next Billion-Dollar Startups List: Nominations Are Open

With this year’s Forbes Next Billion-Dollar Startups list, we’re looking for companies like alumni DoorDash, Benchling and Alchemy in their nascent days.

How Much Money Are At-Home Covid-19 Tests Bringing In?

Eight of the most prominent test makers are navigating a whiplash marketplace.

How The Cleveland Inventors Behind Nottingham Spirk Went From Consumer Products To Medical Devices

Cleveland inventors John Nottingham and John Spirk made a name for themselves designing consumer products. Now they’re cranking up their work on medical devices with 16 healthcare projects last year alone.

Next Billion-Dollar Startups: How Viz.ai Helps Hospitals Treat Stroke Patients Earlier (Video)

When a stroke patient arrives at the ER every minute counts. Viz.ai uses artificial intelligence to treat patients earlier.

Maker Of Home Blood-Draw Kits, Tasso, Raises $100 Million Led By RA Capital

Seattle-based Tasso, founded by two biomedical engineering Ph.D.’s, raises $100 million to ramp up production of its home blood-draw kits.

The Billionaire Chairman Of Vaccine Maker Moderna Wants To Reinvent Scientific Entrepreneurship

Noubar Afeyan launched 70 companies by pushing researchers to ask what if their craziest ideas were true. With $17 billion and a model of “parallel entrepreneurship,” he can fund a lot of wild notions.

Fantastic Voyage-Inspired Miniature Surgical Robot Aims To Revolutionize Abdominal Surgery

Vicarious Surgical, backed by Bill Gates and now going public in a SPAC deal, hopes to reach $1 billion in revenue by 2027 as it takes on the goliath of surgical robots.

‘One Billion Doses On Day One’: Vaccine Company Claims World-Changing Innovation

It’s hard to flawlessly churn out billions of doses of drugs – and we aren’t doing a great job of it. A Midas List VC pulled together a dream team that says it’s come up with a better, faster way.

Biotech R&D Startup Benchling Hits $4 Billion Valuation As The Company Starts Laying Groundwork For An IPO

Sajith Wickramasekara was just 24 when he got on Forbes 30 Under 30 list for his biotech R&D startup Benchling. Now his company is worth $4 billion with a new $200 million round led by Sequoia.

How Materialise’s Founding Couple 3D Printed A Billion-Dollar Fortune

Fried Vancraen and Hilda Ingelaere founded 3D printing company Materialise 30 years ago. Today, their stake in the business is worth $1.3 billion. Here’s how they did it.